ETFIQData as of Nov 18, 2026. · etfiq.com/funds/gmov

GMOV Fact Sheet: GMO U.S. Value ETF

Share
$32.17
close, Nov 18, 2026

Over the year to Nov 18, 2026, GMOV returned +25.1% in total and charged 0.50% a year.

1-year total return
+25.1%
to Nov 18, 2026
Expense ratio
0.50%
a year
Net flow, 12 months to Aug 31, 2026
+$36.9m
monthly N-PORT basis to Aug 31, 2026

Growth of $10,000, 1 year

GMOV $12,513 +25.1% · PBUS $11,148 +11.5% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month−1.5%
3 months−1.0%
Year to date+18.9%
1 year+25.1%
Since launch+34.7%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Microsoft Corp7.37%
Meta Platforms Inc5.35%
ExxonMobil Holdings Corp3.52%
Merck & Co Inc3.14%
Verizon Communications Inc2.54%
JPMorgan Chase & Co2.48%
Pfizer Inc2.41%
Bank of America Corp2.15%
Bristol-Myers Squibb Co2.06%
Johnson & Johnson2.01%

GMOV top ten by weight, 33.0% of the fund, of its 162 equity positions, from the holdings filed for Aug 31, 2026.

Facts

Equity fund · Actively managed · First traded Oct 29, 2024 · Benchmark Its own holdings, as of Aug 31, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, GMOV Fact Sheet: GMO U.S. Value ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/gmov/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/gmov.